Studies of SLC12A3 suggested that its genetic variants and rare mutations impact the development of hypertension and T2DM and/or nephropathy in Asian populations [31–33], which is consistent with the results of our study. This evidence concerns the gene SLC12A3 and hypertensive disorder.